These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1665328)

  • 21. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure.
    Micheletti R; Palazzo F; Barassi P; Giacalone G; Ferrandi M; Schiavone A; Moro B; Parodi O; Ferrari P; Bianchi G
    Am J Cardiol; 2007 Jan; 99(2A):24A-32A. PubMed ID: 17239701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The force-velocity relation and end systolic tension-length relation of hypertrophied myocardium in renal hypertensive rats].
    Ding XL; Li Y
    Sheng Li Xue Bao; 1991 Oct; 43(5):457-63. PubMed ID: 1839082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
    Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
    J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiovascular effects of thyroid hormones].
    Mohr-Kahaly S; Kahaly G; Meyer J
    Z Kardiol; 1996; 85 Suppl 6():219-31. PubMed ID: 9064969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal and hypertrophied senescent rat heart: mechanical and molecular characteristics.
    Besse S; Assayag P; Delcayre C; Carre F; Cheav SL; Lecarpentier Y; Swynghedauw B
    Am J Physiol; 1993 Jul; 265(1 Pt 2):H183-90. PubMed ID: 8342633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical, energetic, and biochemical changes in long-term pressure overload of rabbit heart.
    Gibbs CL; Wendt IR; Kotsanas G; Young IR; Woolley G
    Am J Physiol; 1990 Sep; 259(3 Pt 2):H849-59. PubMed ID: 2144403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biological limits of cardiac adaptation to chronic overload.
    Swynghedauw B
    Eur Heart J; 1990 Nov; 11 Suppl G():87-94. PubMed ID: 2150042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The partitioning of altered mechanics in hypertrophied heart muscle between the sarcoplasmic reticulum and the contractile apparatus by means of myothermal measurements.
    Alpert NR; Mulieri LA
    Basic Res Cardiol; 1977; 72(2-3):153-9. PubMed ID: 140657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward safe inotropic therapy.
    Rajapreyar IN; Ennezat PV; Le Jemtel TH
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):385-92. PubMed ID: 24785344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiac relaxation in experimental chronic myocardial hypertrophy: role of the sarcoplasmic reticulum].
    Lecarpentier Y; Martin JL; Grillon G; Dos Santos A; Antonetti A; Hatt PY
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):820-5. PubMed ID: 6236768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elastic and contractile properties of the myocardium in experimental cardiac hypertrophy of the rat. Methodological and pathophysiological considerations.
    Jacob R; Brenner B; Ebrecht G; Holubarsch C; Medugorac I
    Basic Res Cardiol; 1980; 75(1):253-61. PubMed ID: 6446296
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiac energetics and the Fenn effect.
    Gibbs CL
    Basic Res Cardiol; 1987; 82 Suppl 2():61-8. PubMed ID: 2959266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of myocardial relaxation in conditions of cardiac remodeling.
    Dukanović N; Jakovljević V; Mujović VM
    Med Pregl; 2009; 62(11-12):555-68. PubMed ID: 20491382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical, structural and mechanical defects of the failing myocardium.
    Newman WH
    Pharmacol Ther; 1983; 22(2):215-47. PubMed ID: 6140689
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of thyrocalcitonin on the functions of the intact and hypertrophied myocardium].
    Merzon AK; Glezer GA; Doviner AD; Briskin AI; Pesikov IaS
    Kardiologiia; 1978 Jul; 18(7):86-91. PubMed ID: 150469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analytical approach to mathematical modelling of the isometric contraction of the hypertrophied myocardium.
    Vit K
    Basic Res Cardiol; 1977; 72(2-3):168-71. PubMed ID: 140659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial oxygen consumption as influenced by isotonic contractions.
    LENTINI EA
    Proc Soc Exp Biol Med; 1962 Apr; 109():869-72. PubMed ID: 14464025
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of isometric exercise testing can replace isotonic testing to detect and evaluate hypertensive populations.
    Cantor A; Liel N
    Am J Cardiol; 1991 Aug; 68(5):565-6. PubMed ID: 1741846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.